vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Spok Holdings, Inc (SPOK). Click either name above to swap in a different company.
Spok Holdings, Inc is the larger business by last-quarter revenue ($33.9M vs $24.8M, roughly 1.4× Ceribell, Inc.). Spok Holdings, Inc runs the higher net margin — 8.7% vs -54.6%, a 63.2% gap on every dollar of revenue. Spok Holdings, Inc produced more free cash flow last quarter ($10.1M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Spok Holdings, Inc. is a global provider of critical communication solutions primarily serving the healthcare industry. It offers unified clinical communication platforms, secure messaging tools, alerting systems, and on-call scheduling software that help care teams coordinate efficiently, cut response times, and boost patient safety across medical facilities.
CBLL vs SPOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $24.8M | $33.9M |
| Net Profit | $-13.5M | $2.9M |
| Gross Margin | 87.3% | 76.7% |
| Operating Margin | -58.9% | 11.6% |
| Net Margin | -54.6% | 8.7% |
| Revenue YoY | — | -0.1% |
| Net Profit YoY | — | -19.6% |
| EPS (diluted) | $-0.35 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $33.9M | ||
| Q3 25 | $22.6M | $33.9M | ||
| Q2 25 | $21.2M | $35.7M | ||
| Q1 25 | $20.5M | $36.3M | ||
| Q4 24 | — | $33.9M | ||
| Q3 24 | $17.2M | $34.9M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $34.9M |
| Q4 25 | $-13.5M | $2.9M | ||
| Q3 25 | $-13.5M | $3.2M | ||
| Q2 25 | $-13.6M | $4.6M | ||
| Q1 25 | $-12.8M | $5.2M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | $-10.4M | $3.7M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $4.2M |
| Q4 25 | 87.3% | 76.7% | ||
| Q3 25 | 88.3% | 78.3% | ||
| Q2 25 | 88.1% | 79.5% | ||
| Q1 25 | 87.9% | 80.1% | ||
| Q4 24 | — | 78.5% | ||
| Q3 24 | 87.3% | 79.5% | ||
| Q2 24 | — | 78.9% | ||
| Q1 24 | — | 79.5% |
| Q4 25 | -58.9% | 11.6% | ||
| Q3 25 | -64.8% | 12.9% | ||
| Q2 25 | -70.5% | 15.1% | ||
| Q1 25 | -69.3% | 16.6% | ||
| Q4 24 | — | 13.7% | ||
| Q3 24 | -57.8% | 14.2% | ||
| Q2 24 | — | 13.2% | ||
| Q1 24 | — | 14.0% |
| Q4 25 | -54.6% | 8.7% | ||
| Q3 25 | -59.6% | 9.5% | ||
| Q2 25 | -64.4% | 12.8% | ||
| Q1 25 | -62.4% | 14.3% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | -60.6% | 10.5% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 12.1% |
| Q4 25 | $-0.35 | $0.13 | ||
| Q3 25 | $-0.37 | $0.15 | ||
| Q2 25 | $-0.38 | $0.22 | ||
| Q1 25 | $-0.36 | $0.25 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | $-1.85 | $0.18 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $25.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $146.4M |
| Total Assets | $195.8M | $206.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $25.3M | ||
| Q3 25 | $168.5M | $21.4M | ||
| Q2 25 | $177.4M | $20.2M | ||
| Q1 25 | $182.7M | $19.9M | ||
| Q4 24 | — | $29.1M | ||
| Q3 24 | $14.1M | $27.8M | ||
| Q2 24 | — | $23.9M | ||
| Q1 24 | — | $23.3M |
| Q4 25 | $155.3M | $146.4M | ||
| Q3 25 | $164.1M | $148.7M | ||
| Q2 25 | $172.2M | $150.9M | ||
| Q1 25 | $180.9M | $151.7M | ||
| Q4 24 | — | $154.7M | ||
| Q3 24 | $-136.0M | $156.3M | ||
| Q2 24 | — | $158.2M | ||
| Q1 24 | — | $160.2M |
| Q4 25 | $195.8M | $206.1M | ||
| Q3 25 | $199.5M | $209.7M | ||
| Q2 25 | $207.7M | $208.7M | ||
| Q1 25 | $213.5M | $204.5M | ||
| Q4 24 | — | $217.1M | ||
| Q3 24 | $47.1M | $216.8M | ||
| Q2 24 | — | $216.4M | ||
| Q1 24 | — | $215.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $11.5M |
| Free Cash FlowOCF − Capex | $-11.0M | $10.1M |
| FCF MarginFCF / Revenue | -44.2% | 29.9% |
| Capex IntensityCapex / Revenue | 0.7% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.93× |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $25.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $11.5M | ||
| Q3 25 | $-11.1M | $8.1M | ||
| Q2 25 | $-7.5M | $7.0M | ||
| Q1 25 | $-11.4M | $2.3M | ||
| Q4 24 | — | $8.4M | ||
| Q3 24 | — | $11.1M | ||
| Q2 24 | — | $7.4M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | $-11.0M | $10.1M | ||
| Q3 25 | $-11.5M | $7.6M | ||
| Q2 25 | $-7.6M | $6.0M | ||
| Q1 25 | $-11.6M | $1.5M | ||
| Q4 24 | — | $7.5M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | -44.2% | 29.9% | ||
| Q3 25 | -50.8% | 22.4% | ||
| Q2 25 | -35.9% | 16.8% | ||
| Q1 25 | -56.4% | 4.2% | ||
| Q4 24 | — | 22.3% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 20.0% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 0.7% | 4.1% | ||
| Q3 25 | 1.6% | 1.6% | ||
| Q2 25 | 0.3% | 2.9% | ||
| Q1 25 | 0.7% | 2.1% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | — | 3.93× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 1.55× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 3.03× | ||
| Q2 24 | — | 2.17× | ||
| Q1 24 | — | 0.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
SPOK
| Paging | $16.8M | 50% |
| Software Operations | $16.0M | 47% |
| License | $1.2M | 4% |